Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Conditions
- Congenital Amegakaryocytic Thrombocytopenia
- Diamond-blackfan Anemia
- Fanconi Anemia
- Leukemia
- Severe Congenital Neutropenia
- Thrombocytopenia
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- DRUG: busulfan
- DRUG: fludarabine phosphate
- PROCEDURE: allogeneic bone marrow transplantation
- PROCEDURE: peripheral blood stem cell transplantation
- PROCEDURE: umbilical cord blood transplantation
- RADIATION: radiation therapy
Sponsor
University of California, San Francisco
Collaborators